company background image
600252 logo

Guangxi Wuzhou Zhongheng GroupLtd XSSC:600252 Stock Report

Last Price

CN¥2.39

Market Cap

CN¥8.2b

7D

-2.8%

1Y

-4.0%

Updated

24 May, 2024

Data

Company Financials

Guangxi Wuzhou Zhongheng Group Co.,Ltd

XSSC:600252 Stock Report

Market Cap: CN¥8.2b

600252 Stock Overview

Guangxi Wuzhou Zhongheng Group Co., Ltd. researches, develops, manufactures, and sells pharmaceuticals in China.

600252 fundamental analysis
Snowflake Score
Valuation2/6
Future Growth0/6
Past Performance1/6
Financial Health5/6
Dividends2/6

Guangxi Wuzhou Zhongheng Group Co.,Ltd Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Guangxi Wuzhou Zhongheng GroupLtd
Historical stock prices
Current Share PriceCN¥2.39
52 Week HighCN¥2.79
52 Week LowCN¥1.90
Beta0.39
1 Month Change6.22%
3 Month Change4.82%
1 Year Change-4.02%
3 Year Change-18.71%
5 Year Change-17.87%
Change since IPO-50.14%

Recent News & Updates

Recent updates

Shareholder Returns

600252CN PharmaceuticalsCN Market
7D-2.8%-3.1%-0.6%
1Y-4.0%-12.1%-10.5%

Return vs Industry: 600252 exceeded the CN Pharmaceuticals industry which returned -12.1% over the past year.

Return vs Market: 600252 exceeded the CN Market which returned -10.5% over the past year.

Price Volatility

Is 600252's price volatile compared to industry and market?
600252 volatility
600252 Average Weekly Movement3.1%
Pharmaceuticals Industry Average Movement5.8%
Market Average Movement7.2%
10% most volatile stocks in CN Market10.5%
10% least volatile stocks in CN Market4.2%

Stable Share Price: 600252 has not had significant price volatility in the past 3 months.

Volatility Over Time: 600252's weekly volatility (3%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
19932,886Yidong Niwww.wz-zhongheng.com

Guangxi Wuzhou Zhongheng Group Co., Ltd. researches, develops, manufactures, and sells pharmaceuticals in China. The company offers xueshuantong for injection, zhonghua dieda pills, fuyanjing capsules, jieshitong tablets, yanjianning tablets, angong niuhuang pills, shedan chuanbei liquid, and fluorescein sodium injection covers range of therapeutic areas, such as cardiovascular and cerebrovascular, neurology, endocrinology, orthopedics, ophthalmology, gynecology, pediatrics, respiratory, urinary system, and other fields.

Guangxi Wuzhou Zhongheng Group Co.,Ltd Fundamentals Summary

How do Guangxi Wuzhou Zhongheng GroupLtd's earnings and revenue compare to its market cap?
600252 fundamental statistics
Market capCN¥8.23b
Earnings (TTM)CN¥156.14m
Revenue (TTM)CN¥3.23b

52.7x

P/E Ratio

2.5x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
600252 income statement (TTM)
RevenueCN¥3.23b
Cost of RevenueCN¥1.47b
Gross ProfitCN¥1.77b
Other ExpensesCN¥1.61b
EarningsCN¥156.14m

Last Reported Earnings

Mar 31, 2024

Next Earnings Date

n/a

Earnings per share (EPS)0.045
Gross Margin54.66%
Net Profit Margin4.83%
Debt/Equity Ratio21.7%

How did 600252 perform over the long term?

See historical performance and comparison

Dividends

0.4%

Current Dividend Yield

22%

Payout Ratio
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.